Tezacaftor Ivacaftor
What is Tezacaftor Ivacaftor Tezacaftor ivacaftor is an orally available ion channel modulator approved for the treatment of cystic fibrosis (CF) in patients 6 years of age and older who are homozygous for the F508del mutation or who have at least 1 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor; …